Vertex Pharmaceuticals' new therapy, zimislecel, has potential to be a "functional cure," experts say. A new stem cell ...

A new case report was published in Volume 16 of Oncotarget on July 23, 2025, titled “Extracorporeal blood filtration leading ...

The pancreas, a gland situated behind the stomach, produces digestive enzymes that break down food and secretes hormones like insulin to regulate blood sugar. The exact cause of pancreatic cancer ...

Medically reviewed by Josephine Hessert, DO You can live without your pancreas; however, it does require you to take medications and make certain diet and lifestyle changes to adjust to life without a ...

When used alongside the existing CA 19-9 test, it was able to diagnose early-stage pancreatic cancer with 85% accuracy. Stock image of a person getting blood drawn. Getty ...

They found a special group of "first responder" cells in the pancreas that are crucial for triggering blood sugar response. Their findings were published in the journal Science Advances .

A new test designed to detect markers in the blood is accurately predicting which patients might be developing pancreatic cancer, meaning they can have potentially life-saving treatment.

In 2022, a pilot study from researchers at UC San Diego and other institutions found that a blood test to detect proteins associated with cancer cells was able to identify 95.5% of stage I ...

Just one drop of blood could reveal if you have pancreatic cancer. A new test called PAC-MANN can pick up signs of the disease in people’s blood, even at an early stage, researchers report ...

Called PAC-MANN, the assay targets pancreatic ductal adenocarcinoma (PDAC), which makes up 80-90% of all pancreatic cancer cases and carries a devastatingly low 9% five-year survival rate.

When researchers combined the blood test with a test for an already-established pancreatic cancer marker called CA 19-9, the accuracy increased to 97% of stage 1 and 2 cancers among the U.S ...

A combination of two chemotherapy drugs show promising results in fighting pancreatic cancer, according to a study presented at the American Society of Clinical Oncology's annual meeting Friday.